JP2003520252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003520252A5 JP2003520252A5 JP2001552942A JP2001552942A JP2003520252A5 JP 2003520252 A5 JP2003520252 A5 JP 2003520252A5 JP 2001552942 A JP2001552942 A JP 2001552942A JP 2001552942 A JP2001552942 A JP 2001552942A JP 2003520252 A5 JP2003520252 A5 JP 2003520252A5
- Authority
- JP
- Japan
- Prior art keywords
- terbinafine
- pharmaceutical composition
- starch
- available
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 7
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 7
- 239000008194 pharmaceutical composition Substances 0.000 description 6
- 229960002722 terbinafine Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical class NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- 229920003085 Kollidon® CL Polymers 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229920003110 Primojel Polymers 0.000 description 1
- -1 Sta-rx® 1500 Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940089474 lamisil Drugs 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 239000008203 oral pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940071117 starch glycolate Drugs 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0001315.1 | 2000-01-20 | ||
| GBGB0001315.1A GB0001315D0 (en) | 2000-01-20 | 2000-01-20 | Organic compounds |
| PCT/EP2001/000562 WO2001052895A1 (en) | 2000-01-20 | 2001-01-18 | Pharmaceutical compositions comprising terbinafine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003520252A JP2003520252A (ja) | 2003-07-02 |
| JP2003520252A5 true JP2003520252A5 (enExample) | 2008-01-24 |
Family
ID=9884039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001552942A Pending JP2003520252A (ja) | 2000-01-20 | 2001-01-18 | テルビナフィン含有医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20030017200A1 (enExample) |
| EP (1) | EP1259261B1 (enExample) |
| JP (1) | JP2003520252A (enExample) |
| AT (1) | ATE297760T1 (enExample) |
| AU (1) | AU2001230195A1 (enExample) |
| DE (1) | DE60111503T2 (enExample) |
| ES (1) | ES2241777T3 (enExample) |
| GB (1) | GB0001315D0 (enExample) |
| PT (1) | PT1259261E (enExample) |
| WO (1) | WO2001052895A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
| AR034813A1 (es) * | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
| ATE346590T1 (de) * | 2001-07-26 | 2006-12-15 | Ethypharm Sa | Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate |
| RU2214237C1 (ru) * | 2002-04-24 | 2003-10-20 | Закрытое акционерное общество "Брынцалов-А" | Противогрибковое средство "брамизил" |
| GB0320854D0 (en) * | 2003-09-05 | 2003-10-08 | Arrow No 7 Ltd | Buccal drug delivery |
| WO2007087188A2 (en) * | 2006-01-20 | 2007-08-02 | Merck & Co., Inc. | Taste-masked tablets and granules |
| GB201511799D0 (en) * | 2015-07-06 | 2015-08-19 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| CA3063288A1 (en) | 2017-05-12 | 2018-11-15 | Mavalon Therapeutics Limited | Substituted heterocyclic compounds as allosteric modulators of group ii metabotropic glutamate receptors |
| CN110200929A (zh) * | 2018-12-14 | 2019-09-06 | 悦康药业集团上海制药有限公司 | 一种含有盐酸特比萘芬的口服片及其制备方法 |
| CN109674757A (zh) * | 2019-02-22 | 2019-04-26 | 济南康和医药科技有限公司 | 一种盐酸特比萘芬组合物及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
| SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
| US4994260A (en) * | 1982-05-28 | 1991-02-19 | Astra Lakemedel Aktiebolag | Pharmaceutical mixture |
| CA1239349A (en) * | 1983-10-10 | 1988-07-19 | Eberhard F. Gottwald | Pharmaceutical composition containing cimetidine |
| JPH0776172B2 (ja) * | 1986-04-16 | 1995-08-16 | 藤沢薬品工業株式会社 | マトリツクス錠 |
| US4894375A (en) * | 1986-09-29 | 1990-01-16 | Merck & Co., Inc. | Method of controlling mycotic infections and compositions therefor |
| US4894592A (en) * | 1988-05-23 | 1990-01-16 | Fusion Systems Corporation | Electrodeless lamp energized by microwave energy |
| US4916161A (en) * | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
| US4975465A (en) * | 1989-03-28 | 1990-12-04 | American Home Products Corporation | Orally administrable ibuprofen compositions |
| US5292520A (en) * | 1990-09-13 | 1994-03-08 | Akzo N.V. | Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer |
| US5661170A (en) * | 1994-03-21 | 1997-08-26 | Woodward Laboratories, Inc. | Antimicrobial compositions and methods for using the same |
| GB9509631D0 (en) * | 1995-05-12 | 1995-07-05 | Sandoz Ltd | Antifungal combination |
| GB9513750D0 (en) * | 1995-07-06 | 1995-09-06 | Sandoz Ltd | Use of allylamines |
| RU2184570C2 (ru) * | 1997-09-30 | 2002-07-10 | Дайити Фармасьютикал Ко., Лтд. | Препараты для орального введения |
| JP2000086503A (ja) * | 1998-09-07 | 2000-03-28 | Pola Chem Ind Inc | 錠剤医薬組成物 |
-
2000
- 2000-01-20 GB GBGB0001315.1A patent/GB0001315D0/en not_active Ceased
-
2001
- 2001-01-18 ES ES01902337T patent/ES2241777T3/es not_active Expired - Lifetime
- 2001-01-18 PT PT01902337T patent/PT1259261E/pt unknown
- 2001-01-18 EP EP01902337A patent/EP1259261B1/en not_active Expired - Lifetime
- 2001-01-18 WO PCT/EP2001/000562 patent/WO2001052895A1/en not_active Ceased
- 2001-01-18 AT AT01902337T patent/ATE297760T1/de not_active IP Right Cessation
- 2001-01-18 JP JP2001552942A patent/JP2003520252A/ja active Pending
- 2001-01-18 US US10/181,639 patent/US20030017200A1/en not_active Abandoned
- 2001-01-18 DE DE60111503T patent/DE60111503T2/de not_active Expired - Fee Related
- 2001-01-18 AU AU2001230195A patent/AU2001230195A1/en not_active Abandoned
-
2010
- 2010-04-12 US US12/758,145 patent/US20100197804A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4334610B2 (ja) | プレガバリンを含有する固形の薬学的組成物 | |
| JP3276962B2 (ja) | 安定な医薬組成物 | |
| CN101175484B (zh) | 可分散波生坦片剂 | |
| BR0009437A (pt) | Amido pré-gelatinizado em uma formulação de liberação controlada | |
| MXPA03008056A (es) | Composiciones farmaceuticas liquidas con sabor oculto. | |
| WO2003017981A1 (en) | Controlled release formulation of clarithromycin or tinidazol | |
| EP1315478A2 (en) | Controlled release formulation of erythromycin or a derivative thereof | |
| JP2003520252A5 (enExample) | ||
| JP2002528502A5 (enExample) | ||
| CZ20024216A3 (cs) | Přípravky s chinolonovými antibiotiky s prodlouženým účinkem a způsob jejich výroby | |
| CA2456604A1 (en) | Pharmaceutical composition comprising lumiracoxib | |
| JP2011516544A5 (enExample) | ||
| JP4090997B2 (ja) | ペリンドプリルの口内分散性薬剤組成物 | |
| EP1496868A1 (en) | Controlled release pharmaceutical compositions of carbidopa and levodopa | |
| ES2241777T3 (es) | Composiciones farmaceuticas que contienen terbinafina. | |
| CA2566331A1 (en) | Oral delivery system | |
| WO2005011666A1 (en) | Stable sustained release oral dosage form of gabapentin | |
| JP3282832B2 (ja) | 持続性錠剤 | |
| HUP0500791A2 (en) | Controlled release formulation of clarithromycin or tinidazol | |
| CN100544709C (zh) | 抗血栓形成的化合物的可在口中分散的药物组合物 | |
| JP5201837B2 (ja) | 口腔内速崩壊錠 | |
| RU2190402C1 (ru) | Противовирусное средство | |
| JP2004136102A (ja) | 義歯用口腔湿潤剤 | |
| WO2022098324A1 (en) | A new pharmaceutical composition produced by lyophylisation method containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide active ingredient or its sodium salt | |
| JPH08143450A (ja) | 徐放化製剤 |